Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 31
Filter
1.
Am J Hematol ; 67(4): 227-33, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11443634

ABSTRACT

Sixty-two adults underwent marrow or blood stem cell transplantation from an HLA-matched related donor using high-dose thiotepa, busulfan, and cyclophosphamide (TBC) as the preparative regimen for treatment of advanced myelodysplastic syndrome (MDS) (refractory anemia with excess blasts with or without transformation) or acute myelogenous leukemia (AML) past first remission. All evaluable patients engrafted and had complete donor chimerism. A grade 3-4 regimen-related toxicity occurred in eight (13%) patients, and a diagnosis of MDS was the only independent risk factor for grade 3-4 regimen-related toxicity (hazard ratio 9.25, P = 0.01). Day-100 treatment-related mortality (TRM) was 19%. Poor-prognosis cytogenetics increased the risk of day-100 TRM (hazard ratio 11.4, P = 0.003), and use of tacrolimus for graft-versus-host disease prophylaxis reduced the risk of day-100 TRM (hazard ratio 0.13, P = 0.027). For all patients, the three-year relapse rate was 43% (95% CI, 28%-58%). Refractoriness to conventional induction chemotherapy prior to transplantation was an independent risk factor for relapse (hazard ratio 10.8, P = 0.02). Three-year survival was 26% (95% CI, 14%-37%); survival rates were 29% for those transplanted for AML in second remission, 31% transplanted for AML in relapse, and 17% with MDS, and there were no independent risk factors for survival. TBC is an active preparative regimen for advanced AML. Patients with advanced MDS appeared to have a higher risk of toxicity and early mortality, and alternative preparative regimens should be considered for these patients.


Subject(s)
Antineoplastic Agents, Alkylating/administration & dosage , Leukemia, Myeloid, Acute/therapy , Myelodysplastic Syndromes/therapy , Transplantation Conditioning , Transplantation, Homologous/standards , Adolescent , Adult , Anemia, Refractory, with Excess of Blasts/therapy , Antineoplastic Agents, Alkylating/toxicity , Bone Marrow Transplantation/adverse effects , Bone Marrow Transplantation/mortality , Bone Marrow Transplantation/standards , Busulfan/administration & dosage , Busulfan/toxicity , Cyclophosphamide/administration & dosage , Cyclophosphamide/toxicity , Female , Hematopoietic Stem Cell Transplantation/adverse effects , Hematopoietic Stem Cell Transplantation/mortality , Hematopoietic Stem Cell Transplantation/standards , Humans , Immunosuppressive Agents/administration & dosage , Immunosuppressive Agents/toxicity , Leukemia, Myeloid, Acute/complications , Leukemia, Myeloid, Acute/mortality , Male , Middle Aged , Multivariate Analysis , Myelodysplastic Syndromes/complications , Myelodysplastic Syndromes/mortality , Thiotepa/administration & dosage , Thiotepa/toxicity , Transplantation Conditioning/standards , Transplantation, Homologous/adverse effects , Treatment Outcome
2.
Neuro Oncol ; 3(3): 193-200, 2001 07.
Article in English | MEDLINE | ID: mdl-11465400

ABSTRACT

Stereotactic biopsy is often performed for diagnostic purposes before treating patients whose imaging studies highly suggest glioma. Indications cited for biopsy include diagnosis and/or the "inoperability" of the tumor. This study questions the routine use of stereotactic biopsy in the initial management of gliomas. At The University of Texas M. D. Anderson Cancer Center, we retrospectively reviewed a consecutive series of 81 patients whose imaging studies suggested glioma and who underwent stereotactic biopsy followed by craniotomy/resection (within 60 days) between 1993 and 1998. All relevant clinical and imaging information was reviewed, including computerized volumetric analysis of the tumors based on pre- and postoperative MRI. Stereotactic biopsy was performed at institutions other than M. D. Anderson in 78 (96%) of 81 patients. The majority of tumors were located either in eloquent brain (36 of 81 = 44%) or near-eloquent brain (41 of 81 = 51%), and this frequently was the rationale cited for performing stereotactic biopsy. Gross total resection (>95%) was achieved in 46 (57%) of 81 patients, with a median extent of resection of 96% for this series. Diagnoses based on biopsy or resection in the same patient differed in 40 (49%) of 82 cases. This discrepancy was reduced to 30 (38%) of 80 cases when the biopsy slides were reviewed preoperatively by each of three neuropathologists at M. D. Anderson. Major neurologic complications occurred in 10 (12.3%) of 81 surgical patients and 3 (3.7%) of 81 patients undergoing biopsy. Surgical morbidity was probably higher in our series than it would be for glioma patients in general because our patients represent a highly selected subset of glioma patients whose tumors present a technical challenge to remove. Stereotactic biopsy is frequently inaccurate in providing a correct diagnosis and is associated with additional risk and cost. If stereotactic biopsy is performed, expert neuropathology consultation should be sought.


Subject(s)
Brain Neoplasms/pathology , Glioma/pathology , Stereotaxic Techniques , Adolescent , Adult , Aged , Aged, 80 and over , Biopsy/methods , Brain Neoplasms/surgery , Female , Glioma/surgery , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Predictive Value of Tests , Retrospective Studies , Risk Factors , Sensitivity and Specificity , Treatment Outcome
3.
J Neurosurg ; 94(2 Suppl): 232-44, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11302626

ABSTRACT

OBJECT: Thoracic or lumbar spine malignant tumors involving both the anterior and posterior columns represent a complex surgical problem. The authors review the results of treating patients with these lesions in whom surgery was performed via a simultaneous anterior-posterior approach. METHODS: The hospital records of 26 patients who underwent surgery via simultaneous combined approach for thoracic and lumbar spinal tumors at our institution from July 1994 to March 2000 were reviewed. Surgery was performed with the patients in the lateral decubitus position for the procedure. The technical details are reported. The mean survival determined by Kaplan-Meier analysis was 43.4 months for the 15 patients with primary malignant tumors and 22.5 months for the 11 patients with metastatic spinal disease. At 1 month after surgery, 23 (96%) of 24 patients who complained of pain preoperatively reported improvements (p < 0.001, Wilcoxon signed-rank test), and eight (62%) of 13 patients with preoperative neurological deficits were functionally improved (p = 0.01). There were nine major complications, five minor complications, and no deaths within 30 days of surgery. Two patients (8%) later underwent surgery for recurrent tumor. CONCLUSIONS: The simultaneous anterior-posterior approach is a safe and feasible alternative for the exposure tumors of the thoracic and lumbar spine that involve both the anterior and posterior columns. Advantages of the approach include direct visualization of adjacent neurovascular structures, the ability to achieve complete resection of lesions involving all three columns simultaneously (optimizing hemostasis), and the ability to perform excellent dorsal and ventral stabilization in one operative session.


Subject(s)
Lumbar Vertebrae/surgery , Neurosurgical Procedures , Spinal Neoplasms/surgery , Thoracic Vertebrae/surgery , Adult , Aged , Female , Follow-Up Studies , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Neoplasm Recurrence, Local , Nervous System/physiopathology , Orthopedic Fixation Devices , Postoperative Complications , Postoperative Period , Radiography , Spinal Neoplasms/diagnosis , Spinal Neoplasms/diagnostic imaging , Survival Analysis
4.
Ann Surg Oncol ; 8(2): 179-86, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11258785

ABSTRACT

BACKGROUND: Nosocomial pneumonia continues to be associated with high morbidity and mortality in cancer patients. METHODS: In an attempt to find an optimal treatment for this infection, nonneutropenic cancer patients with postoperative nosocomial pneumonia were randomized to receive either piperacillin/tazobactam (P/T) 4.5 g i.v. every 6 hours (30 patients) or clindamycin (Cl) 900 mg plus aztreonam (Az) 2 g i.v. every 8 hours (22 patients). Amikacin 500 mg i.v. every 12 hours was given to all patients for the first 48 hours. RESULTS: The two groups were comparable for the characteristics of pneumonia that included gram-negative etiology and duration of intubation. Response rates were 83% for patients who received P/T and 86% for those who received Cl/Az (P > .99). There were no serious adverse events; however, at our center the cost of the P/T regimen was $73.86 compared with $99.15 for the Cl/Az regimen. CONCLUSIONS: The two regimens had comparable high efficacy, and P/T had a slight cost advantage. Either of these antibiotic regimens combined with an aminoglycoside could lead to favorable outcome in cancer patients at high risk for nosocomial pneumonia.


Subject(s)
Cross Infection/drug therapy , Drug Therapy, Combination/therapeutic use , Neoplasms/complications , Opportunistic Infections/drug therapy , Penicillanic Acid/analogs & derivatives , Pneumonia, Bacterial/drug therapy , Postoperative Complications/drug therapy , Aged , Amikacin/administration & dosage , Aztreonam/administration & dosage , Chi-Square Distribution , Clindamycin/administration & dosage , Humans , Middle Aged , Penicillanic Acid/administration & dosage , Piperacillin/administration & dosage , Prognosis , Prospective Studies , Tazobactam
5.
J Neurosurg ; 94(1 Suppl): 25-37, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11147865

ABSTRACT

OBJECT: Few reports are available on the use of pedicle screw fixation for cancer-related spinal instability. The authors present their experience with pedicle screw fixation in the management of malignant spinal column tumors. METHODS: Records for patients with malignant spinal tumors who underwent pedicle screw fixation at the authors' institution between September 1994 and December 1999 were retrospectively reviewed. RESULTS: Ninety-five patients with malignant spinal tumors underwent 100 surgeries involving pedicle screw fixation: metastatic spinal disease was present in 81 patients, and locally invasive tumors were demonstrated in 14 patients. Indications for surgery were pain (98%) and/or neurological dysfunction (80%). A posterior (48%) or a combined anterior-posterior (52%) approach was performed depending on the extent of tumor and the patient's condition. At the mean follow up of 8.2 months, 43 patients (45%) had died; median survival, as determined by Kaplan-Meier analysis, was 14.8 months. At I month postsurgery, self-reported pain had improved in 87% of cases (p < 0.001), which is a finding substantiated by reductions in analgesic use, and 29 (47%) of 62 patients with preoperative neurological impairments were functionally improved (p < 0.001). Postoperative complications were associated only with preoperative radiation therapy (p = 0.002) and with preexisting serious medical conditions (p = 0.04). In two patients asymptomatic violation of the lateral wall of the pedicle was revealed on postoperative radiography. The 30-day mortality rate was 1%. CONCLUSIONS: For selected patients with malignant spinal tumors, pedicle screw fixation after tumor resection may provide considerable pain relief and restore or preserve ambulation with acceptable rates of morbidity and mortality.


Subject(s)
Bone Screws , Spinal Neoplasms/surgery , Adolescent , Adult , Aged , Female , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Nervous System/physiopathology , Pain/physiopathology , Postoperative Complications , Postoperative Period , Preoperative Care/adverse effects , Radiotherapy/adverse effects , Retrospective Studies , Spinal Neoplasms/diagnosis , Spinal Neoplasms/physiopathology , Spinal Neoplasms/secondary , Survival Analysis , Treatment Outcome
6.
Neurosurg Focus ; 10(5): E4, 2001 May 15.
Article in English | MEDLINE | ID: mdl-16724827

ABSTRACT

OBJECT: Partial resection of the orbital bones is not uncommon during the excision of anterior and anterolateral skull base tumors. Controversy exists regarding the need for and extent of the reconstruction necessary following this resection. The authors studied this factor in a series of patients. METHODS: The authors conducted a retrospective review of 56 patients in whom resection of 57 anterior or anterolateral skull base tumors and partial excision of the orbital bone were performed. Adverse ophthalmological outcomes were noted in 16 patients, in nine of whom adverse outcomes were believed to be directly related to resection of the orbital walls. Some degree of orbital reconstruction was performed during 23 of the 57 procedures. An adverse orbit-related outcome was strongly associated with resection of the orbital floor and with resection of two thirds or more of two or more orbital walls but not with the presence of absence or orbital reconstruction. The latter finding, however, is likely a function of selection bias. CONCLUSIONS: In most patients after partial excision of the orbital bones, elaborate reconstruction is not necessary. Isolated medial and lateral orbital wall defects or combined superior and lateral orbital wall defects, especially in cases in which the periorbita is intact, probably do not require primary reconstruction. In cases of orbital floor defects, whether isolated or part of a multiple wall resection, primary reconstruction is recommended.


Subject(s)
Craniotomy/methods , Ophthalmologic Surgical Procedures/methods , Orbital Neoplasms/surgery , Plastic Surgery Procedures/methods , Skull Base Neoplasms/surgery , Treatment Outcome , Female , Humans , Magnetic Resonance Imaging/methods , Male , Orbit/surgery , Retrospective Studies , Skull Base/surgery , Tomography, X-Ray Computed/methods
7.
J Neurosurg ; 95(2): 190-8, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11780887

ABSTRACT

OBJECT: The extent of tumor resection that should be undertaken in patients with glioblastoma multiforme (GBM) remains controversial. The purpose of this study was to identify significant independent predictors of survival in these patients and to determine whether the extent of resection was associated with increased survival time. METHODS: The authors retrospectively analyzed 416 consecutive patients with histologically proven GBM who underwent tumor resection at the authors' institution between June 1993 and June 1999. Volumetric data and other tumor characteristics identified on magnetic resonance (MR) imaging were collected prospectively. CONCLUSIONS: Five independent predictors of survival were identified: age, Karnofsky Performance Scale (KPS) score, extent of resection, and the degree of necrosis and enhancement on preoperative MR imaging studies. A significant survival advantage was associated with resection of 98% or more of the tumor volume (median survival 13 months, 95% confidence interval [CI] 11.4-14.6 months), compared with 8.8 months (95% CI 7.4-10.2 months; p < 0.0001) for resections of less than 98%. Using an outcome scale ranging from 0 to 5 based on age, KPS score, and tumor necrosis on MR imaging, we observed significantly longer survival in patients with lower scores (1-3) who underwent aggressive resections, and a trend toward slightly longer survival was found in patients with higher scores (4-5). Gross-total tumor resection is associated with longer survival in patients with GBM, especially when other predictive variables are favorable.


Subject(s)
Brain Neoplasms/mortality , Brain Neoplasms/surgery , Glioblastoma/mortality , Glioblastoma/surgery , Adult , Aged , Brain Neoplasms/pathology , Female , Glioblastoma/pathology , Humans , Karnofsky Performance Status , Magnetic Resonance Imaging , Male , Middle Aged , Multivariate Analysis , Necrosis , Predictive Value of Tests , Prognosis , Retrospective Studies , Survival Rate , Treatment Outcome
8.
Arch Intern Med ; 160(17): 2659-64, 2000 Sep 25.
Article in English | MEDLINE | ID: mdl-10999981

ABSTRACT

BACKGROUND: Candida krusei is inherently resistant to fluconazole and is emerging as a frequent cause of fungemia in patients with hematologic malignant neoplasms. OBJECTIVE: To determine the risk and prognostic factors associated with C krusei fungemia in comparison with Candida albicans fungemia in patients with cancer. METHODS: Retrospective study of 57 cases of C krusei fungemia occurring at the M. D. Anderson Cancer Center, Houston, Tex, from 1989 to 1996. The C krusei cases were compared with 57 cases of C albicans fungemia with respect to demographics, underlying cancer, Acute Physiology and Chronic Health Evaluation II score, immunosuppression status, chemotherapy, and the use of central venous catheters, as well as fluconazole prophylaxis. RESULTS: At our institution, C krusei accounted for 5% of fungemias during 1989 through 1992 and for 10% during 1993 through 1996. Patients with C krusei fungemia more often had leukemia than patients with C albicans (77% vs 11%; P =.02), whereas catheter-related infections were more common among patients with C albicans fungemia (42% vs 0%; P<.001). Patients with C krusei fungemia had a lower response rate (51% vs 69%; P =.05), largely because they more frequently were neutropenic and had disseminated infection. Mortality related to fungemia was 49% in the cases with C krusei vs 28% in C albicans. Multiple logistic regression analysis showed that persistent neutropenia (P =.02) and septic shock (P =.002) were predictors of poor prognosis. CONCLUSION: In neutropenic patients, C krusei fungemia is associated with high mortality. It should be suspected in patients with leukemia who are receiving fluconazole prophylaxis and should be treated aggressively with an amphotericin B regimen.


Subject(s)
Antifungal Agents/therapeutic use , Fungemia/drug therapy , Fungemia/microbiology , Hematologic Neoplasms , Immunocompromised Host , Adolescent , Adult , Aged , Aged, 80 and over , Amphotericin B/therapeutic use , Antineoplastic Agents/adverse effects , Candida albicans/drug effects , Case-Control Studies , Catheterization, Central Venous/adverse effects , Catheters, Indwelling/adverse effects , Child , Child, Preschool , Drug Resistance, Microbial , Female , Fluconazole/therapeutic use , Fungemia/etiology , Hematologic Neoplasms/therapy , Humans , Immunosuppressive Agents/adverse effects , Infant , Logistic Models , Male , Middle Aged , Neutropenia/etiology , Prognosis , Retrospective Studies , Risk Factors , Shock, Septic/etiology , Treatment Outcome
9.
J Neurosurg ; 92(2 Suppl): 181-90, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10763689

ABSTRACT

OBJECT: A unique method of anterior spinal reconstruction after decompressive surgery was used to prevent methylmethacrylate-dural contact in cancer patients who underwent corpectomy. The purpose of this study was to assess the efficacy and stability of polymethylmethacrylate (PMMA) anterior surgical constructs in conjunction with anterior cervical plate stabilization (ACPS) in these patients. METHODS: Approximately 700 patients underwent spinal surgery at The University of Texas M. D. Anderson Cancer Center over a 4-year period. The authors conducted a retrospective outcome study for 29 of these patients who underwent anterior cervical or upper thoracic tumor resections while in the supine position. These patients were all treated using the coaxial, double-lumen, PMMA technique for anterior spinal reconstruction with subsequent ACPS. No postoperative external orthoses were used. Twenty-seven patients (93%) harbored metastatic spinal lesions and two (7%) harbored primary tumors. At 1 month postsurgery, significant improvement was seen in spinal axial pain (p<0.001), radiculopathy (p<0.001), gait (p = 0.008), and Frankel grade (p = 0.002). A total of nine patients (31%) underwent combined anterior-posterior 360 degrees stabilization. Twenty-one patients (72%) experienced no complications. Complications related to instrumentation failure occurred in only two patients (7%). There were no cases in which the patients' status worsened, and there were no neurological complications or infections. The median Kaplan-Meier survival estimate for patients with spinal metastases was 9.5 months. At the end of the study, 13 patients (45%) had died and 16 (55%) were alive. Postoperative magnetic resonance images consistently demonstrated that the dura and PMMA in all patients remained separated. CONCLUSIONS: The anterior, coaxial, double-lumen, PMMA reconstruction technique provides a simple means of spinal cord protection in patients in the supine position while undergoing surgery and offers excellent results in cancer patients who have undergone cervical vertebrectomy.


Subject(s)
Bone Substitutes , Cervical Vertebrae/surgery , Methylmethacrylate , Spinal Cord Compression/surgery , Spinal Neoplasms/secondary , Thoracic Vertebrae/surgery , Adult , Aged , Bone Plates , Cervical Vertebrae/diagnostic imaging , Decompression, Surgical , Female , Follow-Up Studies , Humans , Male , Middle Aged , Postoperative Complications/diagnostic imaging , Radiography , Retrospective Studies , Spinal Cord Compression/diagnostic imaging , Spinal Fusion/instrumentation , Spinal Neoplasms/diagnostic imaging , Spinal Neoplasms/surgery , Surgical Instruments , Thoracic Vertebrae/diagnostic imaging
10.
Arch Intern Med ; 160(4): 501-9, 2000 Feb 28.
Article in English | MEDLINE | ID: mdl-10695690

ABSTRACT

BACKGROUND: Pseudomonas aeruginosa bacteremia is a serious and possibly fatal condition in patients with cancer. OBJECTIVES: To ascertain the frequency, demographics, and predisposing factors for P. aeruginosa bacteremia in patients with cancer and to determine the efficacy of various therapeutic regimens. SUBJECTS AND METHODS: Patient records of the Clinical Microbiology Laboratory, The University of Texas, M. D. Anderson Cancer Center, Houston, were reviewed. From January 1, 1991, through December 31, 1995, 245 eligible cases of P. aeruginosa bacteremia were identified. We examined the patient records for the underlying malignant neoplasm and its management, symptoms and signs of infection, culture results of appropriate specimens, antibiotic therapy, and outcome. We also compared our present experience with a previous analysis from this institution covering the period from January 1, 1972, to December 31, 1981. RESULTS: The incidence of P. aeruginosa bacteremia has decreased compared with the previous study (2.8 vs 4.7 cases per 1000 admissions). It was most common in patients with acute leukemia (55 of 1000 registrations), and the frequency in this disease has not changed. Half of the patients were not in the hospital when they developed their infection. The overall cure rate was 80%, which was a significant (P<.001) increase compared with the 62% cure rate in the previous study. In this study, no significant difference in the cure rates was observed between monotherapy with a beta-lactam and combination therapy overall (P = .72), and in patients with shock (P = 1.0) and those with pneumonia (P = .60). The patients' initial neutrophil counts were not of prognostic value; however, the cure rate depended on subsequent changes in neutrophil count during therapy. CONCLUSIONS: The frequency rate of P. aeruginosa bacteremia has decreased in patients with solid tumors but has remained unchanged in patients with acute leukemia. Antibiotic regimens for empirical therapy of neutropenic patients and especially patients with acute leukemia should still provide coverage against P. aeruginosa.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Antineoplastic Agents/adverse effects , Neoplasms/drug therapy , Neutropenia/complications , Pseudomonas Infections/drug therapy , Pseudomonas Infections/etiology , Pseudomonas aeruginosa , Acute Disease , Adolescent , Adult , Aged , Aged, 80 and over , Child , Child, Preschool , Female , Humans , Incidence , Infant , Lactams , Leukemia/drug therapy , Male , Microbial Sensitivity Tests , Middle Aged , Neutropenia/chemically induced , Pseudomonas Infections/microbiology , Retrospective Studies , Treatment Outcome
11.
Bone Marrow Transplant ; 24(6): 665-9, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10490734

ABSTRACT

In a retrospective study, we compared the incidence and risk of mortality associated with CMV disease in adult allogeneic BMT and PBSC recipients who received ganciclovir prophylaxis three-times-per-week (78 patients) vs five-times-per-week (137 patients). Active CMV infection occurred in 28 (41%) and 26 (21%) in the three- vs five-times-per-week groups, respectively (P < 0.005). CMV disease developed in 11 (16%) and five (4%) patients who received ganciclovir prophylaxis in the three-times-per-week vs five-times-per-week groups (P < 0.004). The CMV-attributable mortality rate was 1.5% and 12% in the five- vsthree-times-per-week groups, respectively (P < 0.003). Risk factors for CMV disease, significant at the P < 0.05 level in the multivariate analysis, were ganciclovir prophylaxis at three-times-per-week, receiving a T cell-depleted (TCD) marrow, and tacrolimus as prophylaxis for GVHD. These data suggest that ganciclovir five-times-per-week significantly reduced the incidence and mortality of CMV disease in allogeneic BMT and PBSC recipients. However, ganciclovir five-times-per-week was less effective for the prevention of CMV disease in patients receiving TCD marrow or tacrolimus.


Subject(s)
Antiviral Agents/therapeutic use , Bone Marrow Transplantation/adverse effects , Cytomegalovirus Infections/prevention & control , Ganciclovir/therapeutic use , Adolescent , Adult , Bone Marrow Transplantation/mortality , Cytomegalovirus Infections/etiology , Female , Ganciclovir/administration & dosage , Ganciclovir/adverse effects , Humans , Lymphocyte Depletion , Male , Middle Aged , Retrospective Studies , Risk Factors , Survival Rate
12.
J Neurosurg ; 90(1 Suppl): 73-8, 1999 Jan.
Article in English | MEDLINE | ID: mdl-10413129

ABSTRACT

OBJECT: Primary chondrosarcoma of the spine is extremely rare. During the last 43 years only 21 patients with this disease were registered at The University of Texas M. D. Anderson Cancer Center. The purpose of this study was to examine the demographic characteristics, treatments, and outcomes of this set of patients. METHODS: Medical records for 21 patients were reviewed. Age, sex, race, clinical presentation, tumor histology, tumor location in the spinal column, treatments, surgical details, and response to treatment were recorded. Surgical procedures were categorized as either gross-total resection or subtotal excision of tumor. Neurological function was assessed using Frankel's functional classification. Time to recurrence and survival analyses were performed using the Kaplan-Meier method. The median age of patients was 51 years, with fairly equal gender representation. Eighteen patients underwent at least one surgical procedure for a total of 28 surgical procedures: seven radical resections and 21 subtotal excisions. Radiation therapy was used in conjunction with 10 of the 28 surgical procedures. The median Kaplan-Meier estimate of overall survival for the entire group was 6 years (range 6 months-17 years). Tumors recurred after 18 of the 28 procedures. Kaplan-Meier analysis revealed a statistically significant difference in the per-procedure disease-free interval after gross-total resection relative to subtotal excision (exact log rank 3.39; p = 0.04). The addition of radiation therapy prolonged the median disease-free interval from 16 to 44 months, although this was not statistically significant (exact log rank 2.63; p = 0.16). CONCLUSIONS: Our results suggest that gross-total resection of the chondrosarcoma provides the best chance for prolonging the disease-free interval in patients. Subtotal excision should be avoided whenever possible. Addition of radiation therapy does not appear to lengthen significantly the disease-free interval in this patient population.


Subject(s)
Chondrosarcoma/surgery , Spinal Neoplasms/surgery , Adult , Aged , Chemotherapy, Adjuvant , Chondrosarcoma/drug therapy , Chondrosarcoma/radiotherapy , Disease-Free Survival , Female , Humans , Male , Medical Records , Middle Aged , Radiotherapy, Adjuvant , Retrospective Studies , Spinal Neoplasms/drug therapy , Spinal Neoplasms/radiotherapy , Survival Analysis , Treatment Outcome
13.
Infect Control Hosp Epidemiol ; 20(2): 101-5, 1999 Feb.
Article in English | MEDLINE | ID: mdl-10064212

ABSTRACT

OBJECTIVE: To determine whether central venous catheter (CVC) dressing changes could be performed by ward nurses rather than by the infusion therapy team (ITT) nurses without increasing the risk of catheter-related infection. DESIGN: Retrospective cohort study using prospectively collected data. The study extended from January 1995 to June 1996. SETTING: The University of Texas M.D. Anderson Cancer Center, a referral cancer center. PATIENTS: The study group was a random sample of 483 patients who received CVC dressing changes by ward nurses during the study period. A random sample of 483 patients who received CVC dressing changes by the ITT constituted the control group. RESULTS: The risks of catheter-related septicemia were 1.7% among cases and 1.4% among controls (risk ratio, 1.14; 95% confidence interval [CI95], 0.26-6.42; P=.70). There also were no significant differences between the two groups in the risks of catheter-related site infection (risk ratio, 0.50; CI95, 0.02-4.12; P=.25) or any catheter-related infection (risk ratio=1.00; CI95, 0.27-3.64; P=.59). CONCLUSIONS: Provided that aseptic techniques (including maximal barrier precautions during insertion) are maintained, the responsibility of CVC dressing changes could be delegated to the ward nurses without increasing the low risk of CVC-related infection, resulting in an estimated cost saving in excess of $90,000 per year.


Subject(s)
Catheterization, Central Venous/adverse effects , Cross Infection/epidemiology , Nursing Staff, Hospital , Patient Care Team , Wound Infection/epidemiology , Adult , Aged , Asepsis , Bandages/microbiology , Cohort Studies , Cross Infection/prevention & control , Female , Humans , Male , Middle Aged , Retrospective Studies , Risk Assessment , Sepsis/epidemiology , Sepsis/nursing , Sepsis/prevention & control , Wound Infection/nursing , Wound Infection/prevention & control
14.
Neurosurgery ; 44(1): 74-9; discussion 79-80, 1999 Jan.
Article in English | MEDLINE | ID: mdl-9894966

ABSTRACT

OBJECTIVE: Sacral chordomas are relatively rare, locally invasive, malignant neoplasms. Despite surgical resection, adjuvant radiation therapy, and chemotherapy, recurrence is common. This study reviews our experience during the last 40 years at The University of Texas M.D. Anderson Cancer Center, to determine the effects of various treatment methods on the overall course of this disease process. METHODS: A retrospective study was performed. From 1954 to 1994, 27 patients with sacral chordomas were evaluated at our institution. RESULTS: There were 19 male and 8 female patients, with a mean age of 56 years (range, 27-80 yr). All except one of the patients presented with pain, and 17 of 27 showed evidence of autonomic dysfunction at initial presentation. Based on microscopic examination of surgical specimen margins, surgical procedures were categorized as either radical resection or subtotal excision. All patients underwent at least one surgical procedure, for a total of 67 procedures (28 radical resections and 39 subtotal excisions). Twelve patients underwent one operation, whereas nine underwent two procedures and six underwent more than two operations (range, 3-16 operations). Radiation therapy was used in conjunction with 13 of the 67 surgical procedures. The median Kaplan-Meier estimate of the overall survival time for the entire group was 7.38 years (range, 4 mo to 34 yr). Tumors recurred after 47 of the 67 procedures. The overall disease-free interval for patients undergoing radical resection was 2.27 years for each procedure, compared with 8 months for each procedure for patients treated with subtotal excision (log-rank test for the inequality between the two curves, 19.58; P<0.0001). The addition of radiation therapy prolonged the disease-free interval for patients undergoing subtotal resection (2.12 yr versus 8 mo; log-rank test for the inequality between the two curves, 5.82; P<0.02). CONCLUSION: Our results suggest frequent recurrences in the majority of patients with chordomas. Radical resection is associated with a significantly longer disease-free interval, compared with subtotal removal of the tumor. Addition of radiation after subtotal resection improves the disease-free interval, although radiation therapy can generally be used only once. Based on these findings, we think that, whenever possible, radical resection should be the treatment of choice for sacral chordomas.


Subject(s)
Chordoma/therapy , Sacrum , Spinal Neoplasms/surgery , Adult , Aged , Cause of Death , Chordoma/mortality , Chordoma/pathology , Combined Modality Therapy , Disease-Free Survival , Female , Humans , Male , Middle Aged , Oncology Service, Hospital , Sacrum/pathology , Spinal Neoplasms/mortality , Spinal Neoplasms/pathology , Texas , Treatment Outcome
15.
Eur J Clin Microbiol Infect Dis ; 17(9): 615-21, 1998 Sep.
Article in English | MEDLINE | ID: mdl-9832262

ABSTRACT

The role of rapidly growing mycobacteria in the pathogenesis of pulmonary disease is being increasingly recognized; however, the clinical significance of these mycobacteria in patients with underlying malignancy has not been well studied. Over a 6-year period, 37 cancer patients with rapidly growing mycobacteria isolated from respiratory specimens were identified at our center. Mycobacterium chelonae group was isolated in 24 cases and Mycobacterium fortuitum in 13 cases. Of the 24 cases with cultures yielding Mycobacterium chelonae group, eight met the study criteria for infection and were determined to be clinically significant, whereas only one of the Mycobacterium fortuitum isolates was determined to represent infection. An average of two antimicrobial agents were used for treatment, most commonly clarithromycin, ciprofloxacin, and trimethoprim/sulfamethoxazole. Although the isolation of rapidly growing mycobacteria represents colonization in most cases, these bacteria, especially the Mycobacterium chelonae group, may cause pulmonary disease in cancer patients. The clinical and radiological findings are usually non-specific in this population, and patients with respiratory cultures yielding rapidly growing mycobacteria should be assessed carefully to distinguish infection from colonization. Effective therapy can be provided with oral regimens that include at least two antibiotics to which the organism is susceptible.


Subject(s)
Lung Diseases/complications , Mycobacterium Infections, Nontuberculous/complications , Mycobacterium chelonae/isolation & purification , Mycobacterium fortuitum/isolation & purification , Neoplasms/complications , Adolescent , Adult , Aged , Aged, 80 and over , Anti-Bacterial Agents , Drug Therapy, Combination/therapeutic use , Female , Humans , Lung/diagnostic imaging , Lung Diseases/diagnostic imaging , Lung Diseases/drug therapy , Lung Diseases/microbiology , Male , Middle Aged , Mycobacterium Infections, Nontuberculous/diagnostic imaging , Mycobacterium Infections, Nontuberculous/drug therapy , Mycobacterium Infections, Nontuberculous/microbiology , Radiography , Treatment Outcome
16.
Infect Control Hosp Epidemiol ; 19(9): 640-2, 1998 Sep.
Article in English | MEDLINE | ID: mdl-9778160

ABSTRACT

OBJECTIVE: To determine the frequency of, and risk factors for, infections associated with intra-arterial catheters used for cancer chemotherapy. METHODS: Between September 1992 and September 1995, we conducted a surveillance study of all 807 intra-arterial catheters placed for chemotherapy at our center. The insertion site was disinfected with povidone iodine and alcohol, and the arterial catheter was placed using maximal sterile barrier precautions. Upon removal, all intravascular segments were submitted for semi-quantitative culture. RESULTS: No episodes of catheter-related bloodstream infection (95% confidence interval [CI95], 0%-1.6%) were observed. However, the risk of colonization (>15 colony-forming units) of arterial catheters was 15% (CI95, 12%-17%). Retrospective risk-factor analysis conducted on 224 intra-arterial catheters placed for chemotherapy in 1993 showed that colonization was associated significantly with duration of catheterization (median of 1 day for culture-negative catheters vs median of 4 days for culture-positive catheters, P<.001). Age, gender, prior radiotherapy, underlying cancer, neutropenia, and hypoalbuminemia were not associated with catheter colonization. CONCLUSION: Intra-arterial catheters for cancer chemotherapy placed under maximal sterile barrier precautions for a short period of time are associated with a very low risk of bloodstream infection.


Subject(s)
Antineoplastic Agents/therapeutic use , Catheters, Indwelling/adverse effects , Cross Infection/etiology , Equipment Contamination , Infusions, Intra-Arterial/instrumentation , Adolescent , Adult , Aged , Aged, 80 and over , Cancer Care Facilities , Colony Count, Microbial , Female , Humans , Incidence , Infection Control/methods , Male , Middle Aged , Prospective Studies , Retrospective Studies , Risk Factors , Texas , Time Factors
17.
J Neurosurg ; 89(4): 599-609, 1998 Oct.
Article in English | MEDLINE | ID: mdl-9761054

ABSTRACT

OBJECT: Anterior approaches to the spine for the treatment of spinal tumors have gained acceptance; however, in most published reports, patients with primary, metastatic, or chest wall tumors involving cervical, thoracic, or lumbar regions of the spine are combined. The purpose of this study was to provide a clear perspective of results that can be expected in patients who undergo anterior vertebral body resection, reconstruction, and stabilization for spinal metastases that are limited to the thoracic region. METHODS: Outcome is presented for 72 patients with metastatic spinal tumors who were treated by transthoracic vertebrectomy at The University of Texas M. D. Anderson Cancer Center. The predominant primary tumors included renal cancer in 19 patients, breast cancer in 10, melanoma or sarcoma in 10, and lung cancer in nine patients. The most common presenting symptoms were back pain, which occurred in 90% of patients, and lower-extremity weakness, which occurred in 64% of patients. All patients underwent transthoracic vertebrectomy, decompression, reconstruction with methylmethacrylate, and anterior fixation with locking plate and screw constructs. Supplemental posterior instrumentation was required in seven patients with disease involving the cervicothoracic or thoracolumbar junction, which was causing severe kyphosis. After surgery, pain improved in 60 of 65 patients. This improvement was found to be statistically significant (p < 0.001) based on visual analog scales and narcotic analgesic medication use. Thirty-five of the 46 patients who presented with neurological dysfunction improved significantly (p < 0.001) following the procedure. Thirty-three patients had weakness but could ambulate preoperatively. Seventeen of these 33 regained normal strength, 15 patients continued to have weakness, and one patient was neurologically worse postoperatively. Of the 13 preoperatively nonambulatory patients, 10 could walk after surgery and three were still unable to walk but showed improved motor function. Twenty-one patients had complications ranging from minor atelectasis to pulmonary embolism. The 30-day mortality rate was 3%. The 1-year survival rate for the entire study population was 62%. CONCLUSIONS: These results suggest that transthoracic vertebrectomy and spinal stabilization can improve the quality of life considerably in cancer patients with spinal metastasis by restoring or preserving ambulation and by controlling intractable spinal pain with acceptable rates of morbidity and mortality.


Subject(s)
Spinal Neoplasms/secondary , Thoracic Vertebrae/surgery , Adult , Aged , Analgesics, Opioid/therapeutic use , Back Pain/surgery , Bone Cements/therapeutic use , Bone Plates , Bone Screws , Breast Neoplasms/pathology , Cervical Vertebrae/surgery , Female , Humans , Kidney Neoplasms/pathology , Kyphosis/surgery , Lumbar Vertebrae/surgery , Lung Neoplasms/pathology , Male , Melanoma/secondary , Melanoma/surgery , Methylmethacrylate , Methylmethacrylates/therapeutic use , Middle Aged , Muscle Weakness/surgery , Pain Measurement , Pain, Intractable/surgery , Pulmonary Atelectasis/etiology , Pulmonary Embolism/etiology , Plastic Surgery Procedures/adverse effects , Plastic Surgery Procedures/instrumentation , Retrospective Studies , Sarcoma/secondary , Sarcoma/surgery , Spinal Neoplasms/surgery , Survival Rate , Treatment Outcome , Walking/physiology
18.
Cancer ; 82(12): 2449-58, 1998 Jun 15.
Article in English | MEDLINE | ID: mdl-9635539

ABSTRACT

BACKGROUND: Imipenem-cilastatin (referred to hereafter as imipenem) is administered at different doses as monotherapy or with other agents. Limited comparisons of the alternatives exist. The authors compared the efficacy and safety of several imipenem-containing regimens (ICRs) to determine the appropriate dose and the need for combination therapy. METHODS: Between 1985 and 1994, febrile neutropenic patients were given ICRs according to the same methodology on prospective trials at a referral cancer center. The ICRs were high dose imipenem (HIP), high dose imipenem and amikacin (HIPA), high dose imipenem and vancomycin (HIPV), and low dose imipenem and vancomycin (LIPV). RESULTS: The overall response rates were comparable (70-77%). There was a univariate trend toward better response among patients with pneumonia and documented infections with unidentified organisms who received HIPV versus LIPV (P=0.06), as well as a significantly better response among patients with gram positive infections who received HIPV versus HIP (P=0.02) and HIPA (P=0.002). HIPV was a more effective treatment for documented infections with identified organisms (P=0.05) and bloodstream infections (P=0.04) than HIP; there was a univariate trend toward better response among patients infected with gram negative organisms who received HIPA versus HIP (P=0.12). Multivariate adjustment for baseline and prognostic factors did not reveal a relative advantage for any regimen. No differences in overall toxicities were observed between HIPV and LIPV. CONCLUSIONS: Imipenem monotherapy is adequate treatment for most febrile neutropenic cancer patients. Low dose imipenem could be effective and safe in uncomplicated cases without pneumonia. Further studies are needed to establish the usefulness of low dose imipenem in this context.


Subject(s)
Cilastatin/administration & dosage , Imipenem/administration & dosage , Neoplasms/complications , Neutropenia/drug therapy , Protease Inhibitors/administration & dosage , Thienamycins/administration & dosage , Adolescent , Adult , Aged , Dose-Response Relationship, Drug , Drug Therapy, Combination , Female , Fever , Humans , Imipenem/adverse effects , Male , Middle Aged , Neutropenia/etiology , Retrospective Studies , Thienamycins/adverse effects , Treatment Outcome
19.
Crit Care Med ; 26(2): 219-24, 1998 Feb.
Article in English | MEDLINE | ID: mdl-9468157

ABSTRACT

OBJECTIVE: To determine the duration of antimicrobial activity and the efficacy of indwelling catheters coated with minocycline and rifampin in preventing ultrastructural colonization. DESIGN: Multicenter, prospective, randomized, clinical trial. SETTING: Five university-based medical centers. PATIENTS: Cohort 1 consisted of 40 randomized patients in whom an equal number of minocycline- and rifampin-coated and uncoated catheters were inserted and studied using scanning electron microscopy. Cohort 2 consisted of 118 patients who received coated catheters that were tested for the antimicrobial activity and levels of the antibiotics at the time of removal. INTERVENTIONS: Catheters pretreated with tridodecylmethylammonium chloride and subsequently coated with minocycline and rifampin; uncoated catheters (control). MEASUREMENTS AND MAIN RESULTS: Quantitative scanning electron microscopy was utilized to determine both the ultrastructural colonization in biofilm on coated and uncoated catheters. The zones of inhibition of coated catheters from studied patients against Staphylococcus epidermidis was used to determine the antimicrobial durability. High-performance liquid chromatography was used to determine antibiotic levels on indwelling coated catheters and in serum. Mild-to-heavy ultrastructural colonization was detected in 7 (35%) of 20 coated catheters and in 16 (80%) of 20 uncoated catheters (p = .004). Significant antimicrobial inhibitory activity against S. epidermidis was maintained for 16 days. Rifampin and minocycline continued to be detected on the surfaces of coated catheters for at least 2 wks after placement. Neither antibiotic was detected in the 60 serum samples obtained from 15 patients during catheterization. CONCLUSION: Coating catheters with minocycline and rifampin inhibits ultrastructural colonization of indwelling catheters and maintains effective antimicrobial activity for at least 2 wks.


Subject(s)
Anti-Bacterial Agents/administration & dosage , Antibiotics, Antitubercular/administration & dosage , Catheterization, Central Venous/instrumentation , Equipment Contamination/prevention & control , Minocycline/administration & dosage , Rifampin/administration & dosage , Adult , Aged , Aged, 80 and over , Catheters, Indwelling/microbiology , Drug Stability , Female , Humans , Male , Microscopy, Electron, Scanning , Middle Aged , Prospective Studies , Texas , Time Factors
20.
Cancer ; 82(2): 403-11, 1998 Jan 15.
Article in English | MEDLINE | ID: mdl-9445199

ABSTRACT

BACKGROUND: The aim of this study was to determine the efficacy of novobiocin and rifampin as oral antibiotic prophylaxis for the prevention of catheter-related infection in melanoma patients treated with interleukin-2 (IL-2) plus interferon-alpha and chemotherapy (biochemotherapy). METHODS: Patients with advanced melanoma who were treated with biochemotherapy at the University of Texas M. D. Anderson Cancer Center were randomized in a crossover study to receive either oral antibiotic prophylaxis consisting of novobiocin and rifampin or observation alone over a 35-day course period. Patients were subsequently "crossed over" to the opposite arm of the study for an additional 35-day period, with each serving as his or her own control. RESULTS: Twenty-six patients were enrolled. Nine patients (35%) failed to tolerate oral antibiotics because of severe nausea and vomiting; 17 patients (65%) were crossed over and considered evaluable. During the control patient courses, 71% of evaluable patients had infectious complications, 41% had a catheter-associated bacteremia, and 53% had a local catheter infection. In contrast, of the patients treated with antibiotic prophylaxis, only 12% had an infectious complication (P = 0.001), 12% had a local catheter infection (P = 0.008), and 6% had catheter-associated bacteremias (P = 0.04). Thirty-six episodes of catheter infections occurred during the 17 control courses, whereas only 3 episodes occurred during antibiotic prophylaxis (P < 0.001). CONCLUSIONS: Although more than one-third of patients receiving IL-2 treatment with biochemotherapy failed to tolerate novobiocin and rifampin, this oral antibiotic regimen was efficacious in preventing the infectious complications, especially those associated with vascular catheters, in this high risk patient population.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Bacterial Infections/prevention & control , Catheters, Indwelling/adverse effects , Interleukin-2/therapeutic use , Melanoma/therapy , Novobiocin/therapeutic use , Rifampin/therapeutic use , Administration, Oral , Adult , Anti-Bacterial Agents/administration & dosage , Antineoplastic Agents/therapeutic use , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Bacteremia/etiology , Bacteremia/prevention & control , Catheterization, Central Venous/adverse effects , Catheterization, Central Venous/instrumentation , Catheterization, Peripheral/adverse effects , Catheterization, Peripheral/instrumentation , Chemoprevention , Cross-Over Studies , Equipment Contamination , Female , Humans , Immunologic Factors/therapeutic use , Interferon-gamma/therapeutic use , Male , Melanoma/drug therapy , Middle Aged , Nausea/chemically induced , Novobiocin/administration & dosage , Prospective Studies , Rifampin/administration & dosage , Vomiting/chemically induced
SELECTION OF CITATIONS
SEARCH DETAIL
...